Stocks and Investing
Stocks and Investing
Wed, April 25, 2012
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:03 AM ] - WOPRAI
[ 05:03 AM ] - WOPRAI
[ 05:02 AM ] - WOPRAI
[ 05:02 AM ] - WOPRAI
[ 05:02 AM ] - WOPRAI
[ 05:01 AM ] - WOPRAI
[ 05:00 AM ] - WOPRAI
[ 04:44 AM ] - Market Wire
[ 03:20 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (BIIB) at Buy with Increased Target to $136 on, Apr 25th, 2012
Jay Olson of Oppenheimer, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $127 to $136 on, Apr 25th, 2012.
Jay has made no other calls on BIIB in the last 4 months.
There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Jay's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jay
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $140 on, Friday, February 10th, 2012